Bioventix (BVXP)

Currency in GBP
1,725.0
0.0(0.00%)
Closed·
High dividend Yield
BVXP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1,650.01,750.0
52 wk Range
1,300.03,020.0
Key Statistics
Bid/Ask
1,600.00 / 1,800.00
Prev. Close
1,725
Open
1,725
Day's Range
1,650-1,750
52 wk Range
1,300-3,020
Volume
7.39K
Average Volume (3m)
11.04K
1-Year Change
-32.3529%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BVXP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

Bioventix News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Mar 30, 2026
EPS / Forecast
0.68 / --
Revenue / Forecast
6.16M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.41%
Dividend Yield
8.96%
Industry Median 1.16%
Annualized payout
150.00
Paid unevenly
5-Years Growth
+9.57%
Growth Streak

BVXP Income Statement

Compare BVXP to Peers and Sector

Metrics to compare
BVXP
Peers
Sector
Relationship
P/E Ratio
12.1x−5.4x−0.5x
PEG Ratio
−2.36−0.020.00
Price/Book
8.2x2.7x2.6x
Price / LTM Sales
7.2x4.6x3.2x
Upside (Analyst Target)
126.1%61.3%47.8%
Fair Value Upside
Unlock8.6%6.7%Unlock

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.08M39.90%35.96M
Other Institutional Investors
2.31M44.23%39.87M
Public Companies & Retail Investors
828.90K15.86%14.30M
Total
5.22M100.00%90.13M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gresham House Asset Management Limited12.16%635,28210,959
Liontrust Asset Management PLC10.62%554,9389,573

People Also Watch

176.20
MONY
-0.90%
405.00
TSTL
+3.32%
4,655.0
JDG
+0.11%
429.30
RMV
-0.95%
254.90
LGEN
+1.27%

FAQ

What Is the Bioventix (BVXP) Stock Price Today?

The Bioventix stock price today is 1,725.0 GBP.

What Stock Exchange Does Bioventix Trade On?

Bioventix is listed and trades on the London Stock Exchange.

What Is the Stock Symbol for Bioventix?

The stock symbol for Bioventix is "BVXP."

Does Bioventix Pay Dividends? What’s The Current Dividend Yield?

The Bioventix dividend yield is 8.7%.

What Is the Bioventix Market Cap?

As of today, Bioventix market cap is 90.13M GBP.

What Is Bioventix's Earnings Per Share (TTM)?

The Bioventix EPS (TTM) is 1.4.

When Is the Next Bioventix Earnings Date?

Bioventix will release its next earnings report on Mar 30, 2026.

From a Technical Analysis Perspective, Is BVXP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Bioventix Stock Split?

Bioventix has split 0 times.

How Many Employees Does Bioventix Have?

Bioventix has 12 employees.

What is the current trading status of Bioventix (BVXP)?

As of May 02, 2026, Bioventix (BVXP) is trading at a price of 1,725.0 GBP, with a previous close of 1,725.0 GBP. The stock has fluctuated within a day range of 1,650.0 GBP to 1,750.0 GBP, while its 52-week range spans from 1,300.0 GBP to 3,020.0 GBP.

What Is Bioventix (BVXP) Price Target According to Analysts?

The average 12-month price target for Bioventix is 3,900.0 GBP, with a high estimate of 3900 GBP and a low estimate of 3900 GBP. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126.09% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.